| DRUG EXPOSURE DURING PREGNANCY | 60 |
| CAESAREAN SECTION | 60 |
| PREMATURE SEPARATION OF PLACENTA | 42 |
| Uterine hyperstimulation | 33 |
| UTERINE HYPERTONUS | 32 |
| DISSEMINATED INTRAVASCULAR COAGULATION | 29 |
| POSTPARTUM HAEMORRHAGE | 28 |
| FOETAL DISTRESS SYNDROME | 25 |
| UTERINE RUPTURE | 23 |
| Foetal heart rate deceleration abnormality | 22 |
| NEONATAL ASPHYXIA | 21 |
| OFF LABEL USE | 19 |
| Foetal death | 19 |
| DRUG INEFFECTIVE | 19 |
| BRADYCARDIA FOETAL | 18 |
| APGAR SCORE LOW | 18 |
| MATERNAL DRUGS AFFECTING FOETUS | 15 |
| Uterine tachysystole | 14 |
| ANAPHYLACTOID SYNDROME OF PREGNANCY | 14 |
| UTERINE CONTRACTIONS ABNORMAL | 12 |
| TACHYCARDIA | 12 |
| MATERNAL EXPOSURE DURING PREGNANCY | 11 |
| DYSPNOEA | 11 |
| DEATH NEONATAL | 11 |
| VOMITING | 10 |
| FOETAL HEART RATE DECELERATION | 10 |
| Vulvovaginal swelling | 9 |
| UTERINE HAEMORRHAGE | 9 |
| Product use issue | 9 |
| MALAISE | 9 |
| Foetal exposure during delivery | 9 |
| VAGINAL HAEMORRHAGE | 8 |
| UTERINE ATONY | 8 |
| TACHYCARDIA FOETAL | 8 |
| Pyrexia | 8 |
| FOETAL HEART RATE ABNORMAL | 8 |
| Contraindicated product administered | 8 |
| COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS | 8 |
| Tremor | 7 |
| STILLBIRTH | 7 |
| HYPOXIC-ISCHAEMIC ENCEPHALOPATHY | 7 |
| HYPERSENSITIVITY | 7 |
| CONVULSION NEONATAL | 7 |
| Vulvovaginal pain | 6 |
| SEPSIS NEONATAL | 6 |
| Nonreassuring foetal heart rate pattern | 6 |
| HYPOTENSION | 6 |
| HAEMORRHAGE | 6 |
| Vulvovaginal erythema | 5 |
| Vulvovaginal dryness | 5 |
| Vulvovaginal discomfort | 5 |
| Pain | 5 |
| Overdose | 5 |
| OEDEMA GENITAL | 5 |
| NAUSEA | 5 |
| MECONIUM STAIN | 5 |
| LABOUR COMPLICATION | 5 |
| HYPERTENSION | 5 |
| Foetal monitoring abnormal | 5 |
| FOETAL HEART RATE DISORDER | 5 |
| FOETAL HEART RATE DECREASED | 5 |
| Exposure during pregnancy | 5 |
| DEATH | 5 |
| BLOOD PH DECREASED | 5 |
| Apnoea | 5 |
| Amniotic cavity infection | 5 |
| ABNORMAL LABOUR | 5 |
| Vulvovaginal burning sensation | 4 |
| SHOCK | 4 |
| PRODUCT QUALITY ISSUE | 4 |
| Precipitate labour | 4 |
| PLACENTAL DISORDER | 4 |
| PHARMACEUTICAL PRODUCT COMPLAINT | 4 |
| PALLOR | 4 |
| METABOLIC ACIDOSIS | 4 |
| Meconium in amniotic fluid | 4 |
| INCORRECT DRUG ADMINISTRATION DURATION | 4 |
| HYSTERECTOMY | 4 |
| HAEMOGLOBIN DECREASED | 4 |
| Foetal exposure during pregnancy | 4 |
| FAILED INDUCTION OF LABOUR | 4 |
| Drug administration error | 4 |
| DISCOMFORT | 4 |
| CEREBRAL PALSY | 4 |
| CARDIO-RESPIRATORY ARREST | 4 |
| ARRESTED LABOUR | 4 |
| ANAPHYLACTIC SHOCK | 4 |
| ABDOMINAL PAIN | 4 |
| Vulvovaginal pruritus | 3 |
| Vulval oedema | 3 |
| Vertigo | 3 |
| Vaginal oedema | 3 |
| UMBILICAL CORD AROUND NECK | 3 |
| Therapeutic product effect incomplete | 3 |
| SYNCOPE | 3 |
| Shock haemorrhagic | 3 |
| Seizure | 3 |
| Product use in unapproved indication | 3 |
| Prescribed overdose | 3 |
| PLACENTAL INSUFFICIENCY | 3 |
| Perineal pain | 3 |
| Obstructed labour | 3 |
| OBSTETRICAL PULMONARY EMBOLISM | 3 |
| NO THERAPEUTIC RESPONSE | 3 |
| MULTI-ORGAN FAILURE | 3 |
| METRORRHAGIA | 3 |
| Loss of consciousness | 3 |
| Intrapartum haemorrhage | 3 |
| INTRA-UTERINE DEATH | 3 |
| HYPOXIC ENCEPHALOPATHY | 3 |
| HYPOXIA | 3 |
| FORCEPS DELIVERY | 3 |
| Foetal acidosis | 3 |
| Dysuria | 3 |
| DIZZINESS | 3 |
| COMPLICATION OF DELIVERY | 3 |
| Cardiac arrest | 3 |
| Bradycardia | 3 |
| BACK PAIN | 3 |
| Asthenia | 3 |
| ANAPHYLACTOID REACTION | 3 |
| ANAPHYLACTIC REACTION | 3 |
| ACUTE PULMONARY OEDEMA | 3 |
| ABNORMAL LABOUR AFFECTING FOETUS | 3 |
| VAGINAL LACERATION | 2 |
| Urinary retention | 2 |
| UNEVALUABLE EVENT | 2 |
| UMBILICAL CORD ABNORMALITY | 2 |
| THROMBOCYTOPENIA | 2 |
| SMALL FOR DATES BABY | 2 |
| SINUS TACHYCARDIA | 2 |
| RESUSCITATION | 2 |
| Restlessness | 2 |
| RESPIRATORY FAILURE | 2 |
| RESPIRATORY DISTRESS | 2 |
| RENAL FAILURE | 2 |
| RASH | 2 |
| Product packaging issue | 2 |
| Product monitoring error | 2 |
| Product administration error | 2 |
| Premature rupture of membranes | 2 |
| PREMATURE BABY | 2 |
| PNEUMONIA | 2 |
| PLACENTA ACCRETA | 2 |
| Patent ductus arteriosus | 2 |
| PARAESTHESIA | 2 |
| PAIN IN EXTREMITY | 2 |
| OXYGEN SATURATION DECREASED | 2 |
| Neonatal respiratory distress syndrome | 2 |
| Neonatal hypoxia | 2 |
| NEONATAL DISORDER | 2 |
| MYOCLONUS | 2 |
| MYOCARDIAL ISCHAEMIA | 2 |
| Muscular weakness | 2 |
| MUSCLE SPASMS | 2 |
| Maternal exposure during delivery | 2 |
| MATERNAL CONDITION AFFECTING FOETUS | 2 |
| Labour pain | 2 |
| IRRITABILITY | 2 |
| Infection | 2 |
| INFARCTION | 2 |
| Incorrect product administration duration | 2 |
| INCORRECT DOSE ADMINISTERED | 2 |
| HYPOTONIA | 2 |
| HEART RATE INCREASED | 2 |
| HEART RATE DECREASED | 2 |
| Headache | 2 |
| Gynaecological examination abnormal | 2 |
| FOREIGN BODY TRAUMA | 2 |
| FOETAL DISORDER | 2 |
| FLUSHING | 2 |
| Fever neonatal | 2 |
| Dysgeusia | 2 |
| Drug monitoring procedure incorrectly performed | 2 |
| Cough | 2 |
| CONVULSION | 2 |
| Condition aggravated | 2 |
| COMPLICATION OF PREGNANCY | 2 |
| CEREBRAL ISCHAEMIA | 2 |
| CARDIOMYOPATHY | 2 |
| CARDIOGENIC SHOCK | 2 |
| Brain injury | 2 |
| Bradycardia neonatal | 2 |
| BLOOD PRESSURE INCREASED | 2 |
| BLOOD PRESSURE DECREASED | 2 |
| Asthma | 2 |
| Abortion induced | 2 |
| Abdominal pain upper | 2 |
| Abdominal pain lower | 2 |
| Wrong technique in product usage process | 1 |
| Wrong product administered | 1 |
| Wrong drug administered | 1 |
| White matter lesion | 1 |
| WEIGHT INCREASED | 1 |
| VISUAL DISTURBANCE | 1 |
| Vision blurred | 1 |
| Vaginal infection | 1 |
| VAGINAL DISORDER | 1 |
| Uterine inflammation | 1 |
| Uterine disorder | 1 |
| UTERINE CONTRACTIONS DURING PREGNANCY | 1 |
| URINARY BLADDER RUPTURE | 1 |
| Urethral stenosis | 1 |
| Urethral disorder | 1 |
| Ureteric injury | 1 |
| UNRESPONSIVE TO STIMULI | 1 |
| Underweight | 1 |
| TROPONIN INCREASED | 1 |
| Treatment failure | 1 |
| Transient tachypnoea of the newborn | 1 |
| TONGUE BITING | 1 |
| TINNITUS | 1 |
| Thyroid disorder | 1 |
| Third stage postpartum haemorrhage | 1 |
| THERAPY NON-RESPONDER | 1 |
| Therapy interrupted | 1 |
| Therapeutic response unexpected | 1 |
| Therapeutic response decreased | 1 |
| THALAMIC INFARCTION | 1 |
| TETANUS | 1 |
| TEMPERATURE INTOLERANCE | 1 |
| Talipes | 1 |
| Tachypnoea | 1 |
| Tachyarrhythmia | 1 |
| SWELLING FACE | 1 |
| SWELLING | 1 |
| Supraventricular tachycardia | 1 |
| Sudden infant death syndrome | 1 |
| Streptococcal sepsis | 1 |
| Status epilepticus | 1 |
| Somnolence | 1 |
| Skin ulcer | 1 |
| SKIN BURNING SENSATION | 1 |
| Shoulder dystocia | 1 |
| Sensitivity to weather change | 1 |
| REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME | 1 |
| Retroplacental haematoma | 1 |
| Retained placenta or membranes | 1 |
| Respiratory disorder | 1 |
| Respiratory arrest | 1 |
| RESPIRATION ABNORMAL | 1 |
| Renal impairment | 1 |
| Renal dysplasia | 1 |
| Raynaud's phenomenon | 1 |
| Rash neonatal | 1 |
| Pyelonephritis acute | 1 |
| Pulse absent | 1 |
| PULMONARY OEDEMA | 1 |
| Puerperal infection | 1 |
| Pruritus | 1 |
| PROTEIN URINE PRESENT | 1 |
| Prolonged labour | 1 |
| Product shape issue | 1 |
| Product physical issue | 1 |
| Procedural haemorrhage | 1 |
| PROCEDURAL COMPLICATION | 1 |
| Presyncope | 1 |
| Premature delivery | 1 |
| Pre-eclampsia | 1 |
| Postpartum sepsis | 1 |
| Postpartum disorder | 1 |
| POSTICTAL STATE | 1 |
| Post procedural haemorrhage | 1 |
| POST PROCEDURAL COMPLICATION | 1 |
| Poisoning deliberate | 1 |
| PO2 DECREASED | 1 |
| Pneumomediastinum | 1 |
| Pleural effusion | 1 |
| Periventricular leukomalacia | 1 |
| Peritonitis | 1 |
| Peritoneal haemorrhage | 1 |
| PERITONEAL HAEMATOMA | 1 |
| Peripheral venous disease | 1 |
| PERIPHERAL CIRCULATORY FAILURE | 1 |
| Pelvic pain | 1 |
| PCO2 INCREASED | 1 |
| OVARIAN HYPERSTIMULATION SYNDROME | 1 |
| OVARIAN HAEMORRHAGE | 1 |
| Osteochondrodysplasia | 1 |
| OPERATIVE HAEMORRHAGE | 1 |
| Oedema peripheral | 1 |
| Obstructive pancreatitis | 1 |
| OBSTETRIC PROCEDURE COMPLICATION | 1 |
| NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL | 1 |
| No adverse event | 1 |
| Neuromuscular blockade | 1 |
| Nervousness | 1 |
| NEONATAL RESPIRATORY DEPRESSION | 1 |
| Neonatal pneumonia | 1 |
| Neonatal infection | 1 |
| NEONATAL ASPIRATION | 1 |
| Nasal flaring | 1 |
| MUSCULOSKELETAL STIFFNESS | 1 |
| Musculoskeletal pain | 1 |
| Moaning | 1 |
| MENINGISM | 1 |
| Medication error | 1 |
| MEDICAL OBSERVATION ABNORMAL | 1 |
| MECONIUM INCREASED | 1 |
| Meconium aspiration syndrome | 1 |
| MATERNAL DISTRESS DURING LABOUR | 1 |
| Maternal death during childbirth | 1 |
| Liver disorder | 1 |
| Lip oedema | 1 |
| Life support | 1 |
| Leukocytosis | 1 |
| LETHARGY | 1 |
| Learning disorder | 1 |
| Lactic acidosis | 1 |
| Jaundice neonatal | 1 |
| Intercepted drug administration error | 1 |
| Influenza like illness | 1 |
| Infected skin ulcer | 1 |
| Infantile apnoea | 1 |
| INCORRECT ROUTE OF DRUG ADMINISTRATION | 1 |
| INADEQUATE ANALGESIA | 1 |
| Ileus paralytic | 1 |
| IATROGENIC INJURY | 1 |
| HYPOVOLAEMIC SHOCK | 1 |
| Hypotonia neonatal | 1 |
| Hypoglycaemia | 1 |
| HYPOCALCAEMIA | 1 |
| Hyperventilation | 1 |
| HYPERTHERMIA | 1 |
| Hypertensive nephropathy | 1 |
| HYPERKALAEMIA | 1 |
| Hypercapnia | 1 |
| Hydrothorax | 1 |
| Hydronephrosis | 1 |
| Hot flush | 1 |
| Hereditary angioedema | 1 |
| Heart rate variability decreased | 1 |
| Heart disease congenital | 1 |
| Haemorrhagic anaemia | 1 |
| Haemoptysis | 1 |
| HAEMODYNAMIC TEST ABNORMAL | 1 |
| HAEMODYNAMIC INSTABILITY | 1 |
| Haematoma | 1 |
| HAEMATOCRIT DECREASED | 1 |
| Haematochezia | 1 |
| Haematemesis | 1 |
| Gestational hypertension | 1 |
| Genital swelling | 1 |
| GENERALISED OEDEMA | 1 |
| GENERAL PHYSICAL CONDITION ABNORMAL | 1 |
| GASTROINTESTINAL PAIN | 1 |
| GASTROINTESTINAL DISORDER | 1 |
| Gait inability | 1 |
| Fungal infection | 1 |
| Foetal arrhythmia | 1 |
| Foetal anaemia | 1 |
| Floppy infant | 1 |
| Fall | 1 |
| Failure to suspend medication | 1 |
| Face oedema | 1 |
| EVACUATION OF RETAINED PRODUCTS OF CONCEPTION | 1 |
| Epilepsy | 1 |
| Endometritis decidual | 1 |
| Endometritis | 1 |
| ELECTROENCEPHALOGRAM ABNORMAL | 1 |
| Eclampsia | 1 |
| Dysphoria | 1 |
| DRUG HYPERSENSITIVITY | 1 |
| Drug effective for unapproved indication | 1 |
| DRUG EFFECT DECREASED | 1 |
| Disease recurrence | 1 |
| Diarrhoea | 1 |
| DEVICE FAILURE | 1 |
| DEVICE EXPULSION | 1 |
| DEVICE BREAKAGE | 1 |
| Depressed level of consciousness | 1 |
| Dehydration | 1 |
| DEFAECATION URGENCY | 1 |
| CYSTITIS HAEMORRHAGIC | 1 |
| Cyanosis neonatal | 1 |
| CYANOSIS | 1 |
| Contraindicated drug administered | 1 |
| CONGENITAL BRAIN DAMAGE | 1 |
| COMPLICATION OF DEVICE REMOVAL | 1 |
| COMA | 1 |
| Coagulopathy | 1 |
| CIRCULATORY COLLAPSE | 1 |
| Cholecystitis chronic | 1 |
| Chills | 1 |
| CHEST PAIN | 1 |
| Chest discomfort | 1 |
| Cervix oedema | 1 |
| Cervix haemorrhage uterine | 1 |
| CERVIX DISORDER | 1 |
| Cerebrovascular accident | 1 |
| Cerebral infarction | 1 |
| CARDIAC FAILURE | 1 |
| Burning sensation | 1 |
| BRONCHOSPASM | 1 |
| Broad ligament haematoma | 1 |
| BREECH DELIVERY | 1 |
| BREAST FEEDING | 1 |
| Brain stem syndrome | 1 |
| Bone hypertrophy | 1 |
| Blood pressure systolic increased | 1 |
| BLOOD LACTATE DEHYDROGENASE INCREASED | 1 |
| BLOOD GASES ABNORMAL | 1 |
| BLOOD FIBRINOGEN INCREASED | 1 |
| BLOOD CULTURE POSITIVE | 1 |
| BLOOD BICARBONATE INCREASED | 1 |
| BLOOD BICARBONATE DECREASED | 1 |
| BLADDER INJURY | 1 |
| ATRIAL THROMBOSIS | 1 |
| Atonic urinary bladder | 1 |
| ATELECTASIS | 1 |
| ASPARTATE AMINOTRANSFERASE INCREASED | 1 |
| Application site pain | 1 |
| Application site oedema | 1 |
| Application site discomfort | 1 |
| Apparent life threatening event | 1 |
| Apparent death | 1 |
| APALLIC SYNDROME | 1 |
| ANTITHROMBIN III DECREASED | 1 |
| ALANINE AMINOTRANSFERASE INCREASED | 1 |
| Agitation | 1 |
| Acute respiratory distress syndrome | 1 |
| Acute kidney injury | 1 |
| ABDOMINAL DISCOMFORT | 1 |
